1. Generics Bulletin

User Fees: Industry Should Push For Extension Of Current Agreement In Reconciliation Bill, Gottlieb Says

 
• By Nielsen Hobbs

Trump’s former FDA commissioner sees ‘nothing good’ coming from negotiating a new user fee agreement in the ‘current political environment.’

Could the user fee reauthorization schedule be stretched out to a more politically conducive time? (Shutterstock)
Key Takeaways
  • A former Trump-era FDA commissioner suggested that industry try to avoid conducting user fee negotiations during the beginning of the new Trump administration.

Scott Gottlieb, who served as US Food and Drug Administration commissioner during the first half of president Trump’s first term,...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from AAM

More from Policy & Regulation